Remove Communication Remove Data Entry Remove Documentation Remove FDA
article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

Ensuring data integrity in the life science industry is crucial for regulatory compliance. Regulatory bodies such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) place great importance on data integrity in the pharmaceutical/life science industry. Good documentation practices.

article thumbnail

Methodology to Define a Pharma 4.0™ Roadmap

ISPE

™ Roadmap Emmie Heeren AREND JAN WASSINK Venkateshwar Rao Nalluri, PhD Sebastian NIEDERHAUSER 1 May 2023 In the context of data integrity, data flows are essential. The FDA, PIC/S, and WHO have all emphasized the importance and benefits of data flows in their guidance on data integrity. initiatives. to Industry 4.0

article thumbnail

How a new investment is powering a revolution in clinical trial operations

pharmaphorum

Clinical trials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck in the past. In most cases, the EHRs and EDCs don’t communicate, so in order to share that data with trial organisers, staff members at medical centres must manually copy data between the EHR and an EDC.